IL-9 as A Potent Drug Target for Immune Cell Regulation and Pain

Target Name: IL9

NCBI ID: G3578

Content of Review Report on IL9 Target / Biomarker

IL9

IL-9 as A Potent Drug Target for Immune Cell Regulation and Pain

IL-9 (Interleukin-9) is a cytokine that plays a crucial role in the immune system. It is a potent chemoattractant that attracts various immune cells, including T-cells and mast cells, to the site of infection or inflammation. The ability of IL-9 to attract these cells to the site of injury or infection makes it an attractive drug target for researchers.

IL-9 has been shown to be involved in a wide range of physiological processes in the body, including inflammation, immune cell regulation, and tissue repair. It is a potent stimulator of the production of white blood cells, including T-cells, and has been shown to play a key role in the development and maintenance of immune tolerance.

One of the unique features of IL-9 is its ability to promote the growth and survival of various types of immune cells, including mast cells. Mast cells are a type of immune cell that are responsible for producing and releasing histamine, a chemical that causes itching and inflammation when reacted with the skin.

The ability of IL-9 to promote the growth and survival of mast cells makes it an attractive drug target for compounds that are designed to treat inflammatory skin conditions, such as atopic dermatitis and contact dermatitis. These conditions are characterized by the production of excessive amounts of histamine, which leads to inflammation and itching.

In addition to its role in immune cell regulation, IL-9 is also involved in the regulation of cellular processes that are important for tissue repair and regeneration. It is a potent stimulator of the production of new cells, including those of the immune system, and has been shown to play a key role in the regulation of cell death.

The high level of activity of IL-9 makes it an attractive drug target for compounds that are designed to stimulate cellular growth and division, including those that are used to treat cancer. IL-9 has also been shown to play a key role in the regulation of the immune response, and is involved in the development and regulation of various types of immune cells, including natural killer cells and T-cells.

IL-9 is also involved in the regulation of the inflammatory response, and has been shown to play a key role in the regulation of various types of inflammation, including inflammatory pain.

In conclusion, IL-9 is a drug target that has the potential to treat a wide range of inflammatory conditions, including atopic dermatitis, contact dermatitis, and various types of cancer. Its ability to promote the growth and survival of immune cells, including mast cells, makes it an attractive target for compounds that are designed to treat these conditions. Further research is needed to fully understand the role of IL-9 in the immune system and to develop safe and effective treatments.

Protein Name: Interleukin 9

Functions: Multifunctional cytokine secreted mainly by T-helper 2 lymphocytes and also mast cells or NKT cells that plays important roles in the immune response against parasites (PubMed:29742432). Affects intestinal epithelial permeability and adaptive immunity (PubMed:29742432). In addition, induces the differentiation of specific T-cell subsets such as IL-17 producing helper T-cells (TH17) and also proliferation and differentiation of mast cells. Mechanistically, exerts its biological effects through a receptor composed of IL9R subunit and a signal transducing subunit IL2RG. Receptor stimulation results in the rapid activation of JAK1 and JAK3 kinase activities leading to STAT1, STAT3 and STAT5-mediated transcriptional programs. Induction of differentiation genes seems to be mediated by STAT1 alone, while protection of cells from apoptosis depends on STAT3 and STAT5

The "IL9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IL9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets